drugset / Trial / NCT02579187

MicroRNA and MicroRNA Inhibitors Socket Study, Pilot Clinical Trial

NCT02579187 ↗

RandomizedParallel-groupSingle-blindHealth-services research

Summary

To evaluate the efficacy of locally delivering plasmid DNAs encoding microRNAs, and/or microRNA inhibitors, in the promotion of osteogenesis and modulation of the inflammatory response on the basis of different clinical, radiographic, histologic and biomolecular outcomes in post-extraction socket defects in humans.

Timeline

Start
2025-12-31
Primary completion
2030-09
Completion
2030-09

Outcome

Outcome not reported

Stopped: “withdrawn study from IRB”

Drugs

EvaluationDrugModalityDoseRoute
Comparator PMIS miR200a Other / unclassified 5 ug Other
Comparator PMIS miR200a Other / unclassified 10 ug Other
Comparator pSil-miR200c Other / unclassified 5 ug Other
Comparator pSil-miR200c Other / unclassified 10 ug Other

Indications

No indication recorded.